Wednesday, June 10, 2026

pharma Β· Recurrent Respiratory Tract Infections Β· Actinic Keratosis on the Face or Scalp

ALMIRALL S.P.A

ALMIRALL S.P.A clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona HQ
2 Employees
NMPA registrant Type
Company details
Status
Public
HQ
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
Employees
2
Programs
11
Drugs
20
Patents
308
Intelligence Β· Clinical Programs

ALMIRALL S.P.A projects

1 ClinicalTrials.gov programs sponsored by ALMIRALL S.P.A.

ALMIRALL S.P.A has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. M-27312-01

    Almirall, S.A.

    Inflammatory diseases

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does ALMIRALL S.P.A have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.